LECTURES ABSTRACTS
| L-1 | THE HEART-BREAK OF STUDYING
GLUCOCORTICOID RECEPTORS AT THE NIH J. Cidlowski (NIH, Research Triangle Park) |
| L-2 | NEW DRUG FOR RARE DISEASE P.L. Zinzani (Bologna) |
| L-3 | NEW THERAPEUTIC APPROACHES IN OVARIAN CANCER S. Pignata (Napoli) |
| L-4 | NEW ORIZONS FOR NEW NEURONS: ADULT-GENERATED NEURONS AND
IMPLICATIONS FOR THE NORMAL AND DISEASED BRAIN A. Eisch (Dallas) |
| L-5 | THE DIFFICULT SEARCH FOR A TRUE INTESTINAL PROKINETIC. THE
PHARMACOLOGY OF PRUCALOPRIDE C. Blandizzi (Pisa) |
| L-6 | A NEW BIOLOGICAL APPROACH FOR THE TREATMENT OF POSTMENOPAUSAL
OSTEOPOROSIS: MECHANISM OF ACTION AND CLINICAL RESULTS L. Sinigaglia (Milano) |
| L-7 | MECHANISM OF ACTION AND NEUROPROTECTION’S POTENTIAL G. Biggio (Cagliari) |
| L-8 | HEPATITIS C IN ITALY: EPIDEMIOLOGICAL IMPACT AND THERAPEUTICAL STRATEGIES A. Gasbarrini (Roma) |
| L-9 | NOE (N-OLEIL-ETANOLAMINA) IN THE CONTROL OF SAFETY AND FOOD
INTAKE: NEW THERAPEUTIC PERSPECTIVES E. Grossi (Milano) |
| L-10 | RANK/RANKL AND OPG: NEW KEY MECHANISM FOR BONE TURNOVER D. Santini (Roma) |
| L-11 | NEW PERSPECTIVES FOR THE PHARMACOLOGICAL TREATMENT OF MALIGNANT
MELANOMA R. Danesi (Pisa) |
| L-12 | BRAF
MUTATIONAL STATUS: A NOVEL BIOMARKER FOR MELANOMA P. A. Ascierto (Napoli) |
| L-13 | THERAPEUTIC APPROPRIATENESS: A NEW PERSPECTIVE F. De Ponti (Bologna) |
| L-14 | NEW INSIGHTS IN THE REGULATION OF ANGIOGENESIS N. Ferrara (San Francisco) |